"Early Results from the FDA Extracellular Matrix (ECM) Cylinder Valve Clinical Feasibility Trial." Structural Heart, 4(sup1), p. 102
Disclosure Statement
The authors do not declare any conflict of interest.
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.
Register now or learn more